Literature DB >> 19943788

Short communication: HIV type 1 genetic diversity among tea plantation workers in Kericho, Kenya.

Miguel A Arroyo1, Warren B Sateren, Ginamarie Foglia, Rukia Kibaya, Lilian Langat, Monique Wasunna, Christian T Bautista, Paul T Scott, Douglas N Shaffer, Merlin L Robb, Nelson L Michael, Deborah L Birx, Francine E McCutchan.   

Abstract

In preparation for HIV-1 vaccine trials in Kenya, 2801 study volunteers, from a tea plantation in Kericho, were recruited as part of a prospective vaccine cohort development study. Cryopreserved plasma was available from 401 HIV-positive volunteers, and was the source of viral RNA for genotyping by the multiregion hybridization assay (MHA). Logistic regression was performed to determine association of risk factors and HIV-1 recombinant and dual infections. At baseline, HIV-1 subtype A was the dominant circulating pure subtype (56%), followed by subtype D (10%) and C (5%). Recombinant HIV-1 strains accounted for almost one-third of all infections (29%), with 7% infected with a dual strain of the HIV-1 variants described. A higher number of HIV-1 recombinant and dual infections was observed among volunteers who were 18-24 and 25-29 years of age, affiliated with the Luo tribe, had been married two or more times, reported not being circumcised, and had STI symptoms in the past 6 months. Adjusted odds ratios (AOR) significantly associated with HIV-1 recombinant and dual infection were age difference from current spouse (5-9 years; AOR = 2.5, 95% CI = 1.2-5.3 and > or = 10 years; AOR = 3.1, 95% CI = 1.5-6.4) and reported STI symptoms in the past 6 months (AOR = 4.8, 95% CI = 2.0-11.6), respectively. In conclusion, our results suggest that there is considerable heterogeneity with respect to HIV-1 subtype diversity in this population that should be considered in the planning for future vaccine trials in the region.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19943788     DOI: 10.1089/aid.2009.0092

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

1.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

2.  Continuous spread of HIV-1 subtypes D and CRF01_AE in France from 2003 to 2009.

Authors:  Denys Brand; Françoise Cazein; Florence Lot; Sylvie Brunet; Damien Thierry; Alain Moreau; Josiane Pillonel; Caroline Semaille; Francis Barin
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

3.  HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.

Authors:  Rami Kantor; Allison DeLong; Maya Balamane; Leeann Schreier; Robert M Lloyd; Wilfred Injera; Lydia Kamle; Fidelis Mambo; Sarah Muyonga; David Katzenstein; Joseph Hogan; Nathan Buziba; Lameck Diero
Journal:  J Int AIDS Soc       Date:  2014-11-18       Impact factor: 5.396

4.  The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.

Authors:  Erik Billings; Eric Sanders-Buell; Meera Bose; Andrea Bradfield; Esther Lei; Gustavo H Kijak; Miguel A Arroyo; Rukia M Kibaya; Paul T Scott; Monique K Wasunna; Frederick K Sawe; Douglas N Shaffer; Deborah L Birx; Francine E McCutchan; Nelson L Michael; Merlin L Robb; Jerome H Kim; Sodsai Tovanabutra
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.